Q-omics provides the consensus-scored FAM106C profile across patient tissues and cancer cell-line models. Additionally, FAM106C RNA expression shows 4,905 significant protein co-abundance associations, with the highest sampling consensus in LUAD.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for FAM106C — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with FAM106C in patient tissues and cancer cell lines. In patient samples, FAM106C shows the broadest associations at the RNA and protein expression levels, with LUAD recurring as the lineage with the largest associated feature set. In cancer cell lines, FAM106C RNA and mutation anchors are most strongly linked to RNA-expression features, especially in SOFT_TISSUE.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	4,905	LUAD (917)	view →
Function (mass-spec)	283	PDAC (48)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼shRNA
RNA	1,023	SOFT_TISSUE (306)	view →
shRNA	961	SOFT_TISSUE (181)	view →